Cargando…
Phase 4 Studies in Heart Failure - What is Done and What is Needed?
Congestive heart failure (CHF) therapeutics is generated through a well-described evidence generating process. Phases 1 – 3 of this process are required prior to approval and widespread clinical use. Phase 3 in almost all cases is a methodologically sound randomized controlled trial (RCT). After thi...
Autores principales: | Iyngkaran, Pupalan, Liew, Danny, McDonald, Peter, Thomas, Merlin C., Reid, Christopher, Chew, Derek, Hare, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011189/ https://www.ncbi.nlm.nih.gov/pubmed/27280303 http://dx.doi.org/10.2174/1573403X12666160606121458 |
Ejemplares similares
-
Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What are the problem
areas and potential solutions?
por: Iyngkaran, Pupalan
Publicado: (2016) -
Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?
por: Iyngkaran, Pupalan, et al.
Publicado: (2019) -
Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age
por: Iyngkaran, Pupalan, et al.
Publicado: (2018) -
Heart Failure Paradigms in the Developed World - A Reflection - Part 1
por: Iyngkaran, Pupalan, et al.
Publicado: (2021) -
Contextualizing Genetics for Regional Heart Failure Care
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)